2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina. (2021). Biomolecules and Biomedicine, 21(2), 120-135. https://doi.org/10.17305/bjbms.2020.4846